In the week of September 8, 2025, 20 holders filed a new Schedule 13D and 63 a new Schedule 13G reporting 5% or more of a company. The largest stake reported that week is Ameriprise Financial, Inc.'s 96.4% of Columbia Credit Income Opportunities Fund (Schedule 13G, September 11, 2025).
The week of 2025-09-08, 20 holders filed a new Schedule 13D and 63 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-09-10 | Big Tree Cloud Holdings Ltd | Ploutos Group Limited | 80.48% | SCHEDULE 13D |
| 2025-09-09 | Mechanics Bancorp | Webb Carl B | 78.1% | SCHEDULE 13D |
| 2025-09-10 | American Bitcoin Corp | Hut 8 Corp. | 64.5% | SCHEDULE 13D |
| 2025-09-11 | Mitesco, Inc. | Anglo Irish Management, LLC | 44.98% | SCHEDULE 13D |
| 2025-09-08 | Charles & Colvard Ltd | Ethara Capital LLC | 42.79% | SCHEDULE 13D |
| 2025-09-09 | Apollomics Inc. | Hung-Wen Chen | 41.8% | SCHEDULE 13D |
| 2025-09-11 | Solowin Holdings, Ltd. | Gemini Asia Holdings Limited | 40.43% | SCHEDULE 13D |
| 2025-09-10 | Lianhe Sowell International Group Ltd | Dengyao Jia | 36.9% | SCHEDULE 13D |
| 2025-09-12 | Fox Corp | Cruden 2, LLC | 36.2% | SCHEDULE 13D |
| 2025-09-12 | News Corp | Cruden 2, LLC | 33.2% | SCHEDULE 13D |
| 2025-09-12 | NIP Group Inc. | Apex Cyber Capital Limited | 31.2% | SCHEDULE 13D |
| 2025-09-10 | PTL Limited | Ying Ying Chow | 30.1% | SCHEDULE 13D |
| 2025-09-12 | NIP Group Inc. | Prosperity Oak Holdings Limited | 29.4% | SCHEDULE 13D |
| 2025-09-08 | Armada Acquisition Corp. II | Arrington XRP Capital Fund, LP | 26.2% | SCHEDULE 13D |
| 2025-09-12 | Talphera, Inc. | CorMedix Inc. | 19.95% | SCHEDULE 13D |
| 2025-09-11 | Allied Gaming & Entertainment Inc. | Digitas Global LLC | 10.3% | SCHEDULE 13D |
| 2025-09-12 | Old Market Capital Corp | The TCW Group, Inc., on behalf of the TCW Business Unit | 8.9% | SCHEDULE 13D |
| 2025-09-10 | American Bitcoin Corp | Eric Trump | 7.5% | SCHEDULE 13D |
| 2025-09-09 | Orasure Technologies Inc | Altai Capital Management, L.P. | 5.13% | SCHEDULE 13D |
| 2025-09-12 | Spirit Aviation Holdings, Inc | Esopus Creek Value Series Fund LP - Series A | 5% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-09-11 | Columbia Credit Income Opportunities Fund | Ameriprise Financial, Inc. | 96.4% | SCHEDULE 13G |
| 2025-09-08 | Tema ETFs LLC | Brown Advisory Inc | 95.7% | SCHEDULE 13G |
| 2025-09-11 | MidCap Apollo Institutional Private Lending | Mubadala Investment Company PJSC | 95.3% | SCHEDULE 13G |
| 2025-09-08 | Tortoise Energy Infrastructure Corp | Prudential Financial Inc | 82.9% | SCHEDULE 13G |
| 2025-09-12 | CISO Global, Inc. | Hensley & Company | 66% | SCHEDULE 13G |
| 2025-09-11 | The Growhub Limited | Chan Choon Yew Lester | 41.24% | SCHEDULE 13G |
| 2025-09-09 | CISO Global, Inc. | JC Associates, Inc | 34% | SCHEDULE 13G |
| 2025-09-09 | D. Boral ARC Acquisition I Corp. | Mfh 1, LLC | 29.61% | SCHEDULE 13G |
| 2025-09-10 | Kolibri Global Energy Inc. | Tetragon Financial Group Limited | 19.8% | SCHEDULE 13G |
| 2025-09-11 | Mistras Group, Inc. | Aspasia Vahaviolos | 19.4% | SCHEDULE 13G |
| 2025-09-08 | Shoulder Innovations, Inc. | Fmr LLC | 19% | SCHEDULE 13G |
| 2025-09-08 | Cslm Acquisition Corp. | Meteora Capital, LLC | 15.8% | SCHEDULE 13G |
| 2025-09-12 | Ibotta, Inc. | Clark Jermoluk Founders Fund I LLC | 15.2% | SCHEDULE 13G |
| 2025-09-08 | GigaCloud Technology Inc | Fmr LLC | 14.8% | SCHEDULE 13G |
| 2025-09-08 | Tortoise Energy Infrastructure Corp | Massachusetts Mutual Life Insurance Company | 14.3% | SCHEDULE 13G |
| 2025-09-08 | Vistagen Therapeutics, Inc. | Janus Henderson Group Plc | 13.6% | SCHEDULE 13G |
| 2025-09-08 | Uranium Energy Corp | T. Rowe Price Associates, Inc. | 12.8% | SCHEDULE 13G |
| 2025-09-08 | Invivyd, Inc. | Janus Henderson Group Plc | 11.6% | SCHEDULE 13G |
| 2025-09-08 | Arcellx, Inc. | T. Rowe Price Investment Management, Inc. | 11.3% | SCHEDULE 13G |
| 2025-09-08 | Wns Hldgs Ltd | FIL Limited | 10.9% | SCHEDULE 13G |
| 2025-09-08 | Evoke Pharma Inc | Morgan Stanley | 10.5% | SCHEDULE 13G |
| 2025-09-08 | Viper Energy, Inc. | The Vanguard Group | 10.08% | SCHEDULE 13G |
| 2025-09-08 | Vanguard Group Inc | International City Management Association Retirement Corp | 10% | SCHEDULE 13G |
| 2025-09-08 | Bnb Plus Corp. | Mitchell P. Kopin | 9.99% | SCHEDULE 13G |
| 2025-09-08 | vTv Therapeutics Inc. | Raymond Debbane | 9.99% | SCHEDULE 13G |
| 2025-09-10 | Purple Biotech Ltd. | Mitchell P. Kopin | 9.99% | SCHEDULE 13G |
| 2025-09-11 | Quantum X Labs Inc. | L.I.A. Pure Capital Ltd. | 9.99% | SCHEDULE 13G |
| 2025-09-11 | Youxin Technology Ltd | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2025-09-12 | Youxin Technology Ltd | S.H.N. Financial Investments Ltd. | 9.99% | SCHEDULE 13G |
| 2025-09-08 | Sera Prognostics, Inc. | Whetstone Capital Advisors, LLC | 9.9% | SCHEDULE 13G |
| 2025-09-08 | vTv Therapeutics Inc. | Trails Edge Capital Partners, LP | 9.9% | SCHEDULE 13G |
| 2025-09-09 | Purple Biotech Ltd. | Orca Capital AG | 9.9% | SCHEDULE 13G |
| 2025-09-09 | Purple Biotech Ltd. | Lincoln Alternative Strategies LLC | 9.9% | SCHEDULE 13G |
| 2025-09-12 | Regen Biopharma, Inc. | Quick Capital, LLC | 9.9% | SCHEDULE 13G |
| 2025-09-12 | Professional Diversity Network, Inc. | Streeterville Capital LLC | 9.9% | SCHEDULE 13G |
| 2025-09-11 | FG Nexus Inc. | Point72 Asset Management, L.P. | 9.8% | SCHEDULE 13G |
| 2025-09-08 | The Beachbody Company, Inc. | Whetstone Capital Advisors, LLC | 8.3% | SCHEDULE 13G |
| 2025-09-12 | Talphera, Inc. | Rock Springs Capital Management LP | 7.88% | SCHEDULE 13G |
| 2025-09-12 | Gamehaus Holdings Inc. | DWC Technology Limited | 7.78% | SCHEDULE 13G |
| 2025-09-10 | Aethlon Medical Inc | Mitchell P. Kopin | 7.7% | SCHEDULE 13G |
| 2025-09-11 | KALA BIO, Inc. | Perceptive Advisors LLC | 7.7% | SCHEDULE 13G |
| 2025-09-09 | enVVeno Medical Corp | Kingdon Capital Management, L.L.C. | 7.1% | SCHEDULE 13G |
| 2025-09-10 | ZimVie Inc. | Glazer Capital, LLC | 7.07% | SCHEDULE 13G |
| 2025-09-08 | STRATA Skin Sciences, Inc. | CVI Investments, Inc. | 6.9% | SCHEDULE 13G |
| 2025-09-10 | Bullish | See Alexander | 6.7% | SCHEDULE 13G |
| 2025-09-11 | KALA BIO, Inc. | Point72 Asset Management, L.P. | 6.7% | SCHEDULE 13G |
| 2025-09-12 | FG Nexus Inc. | Citadel Advisors LLC | 6.6% | SCHEDULE 13G |
| 2025-09-08 | Crinetics Pharmaceuticals, Inc. | Dapice Joshua J. | 6% | SCHEDULE 13G |
| 2025-09-09 | Agassi Sports Entertainment Corp. | Boreta John Anthony | 6% | SCHEDULE 13G |
| 2025-09-12 | Etsy Inc | Kenneth Griffin | 6% | SCHEDULE 13G |
| 2025-09-08 | SurgePays, Inc. | Bradley James Crosby | 5.96% | SCHEDULE 13G |
| 2025-09-08 | electroCore, Inc. | Hilve Holdings Ltd | 5.7% | SCHEDULE 13G |
| 2025-09-10 | Qvc Group Inc | John C. Broderick | 5.7% | SCHEDULE 13G |
| 2025-09-08 | Health Catalyst, Inc. | Whetstone Capital Advisors, LLC | 5.4% | SCHEDULE 13G |
| 2025-09-08 | GSR IV Acquisition Corp. | Linden Capital L.P. | 5.3% | SCHEDULE 13G |
| 2025-09-11 | Mistras Group, Inc. | Kristy Kyriakopoulos | 5.3% | SCHEDULE 13G |
| 2025-09-12 | Dianthus Therapeutics Inc | Point72 Asset Management, L.P. | 5.3% | SCHEDULE 13G |
| 2025-09-08 | Kezar Life Sciences, Inc. | Stonepine Capital Management, LLC | 5.2% | SCHEDULE 13G |
| 2025-09-11 | Sotera Health Co | Sculptor Capital LP | 5.19% | SCHEDULE 13G |
| 2025-09-11 | Mistras Group, Inc. | Stephanie Foglia | 5.1% | SCHEDULE 13G |
| 2025-09-12 | G-III Apparel Group Ltd | cobas asset management, sgiic, s.a. | 5.1% | SCHEDULE 13G |
| 2025-09-10 | Saia Inc | Viking Global Investors LP | 5.02% | SCHEDULE 13G |
| 2025-09-08 | General Fusion Group Ltd. | Tenor Capital Management Company, L.P. | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.